Anthony Nigro | Researchain

Archive Network Publication Hotspot Collaboration

Network

Latest external collaboration on country level. Dive into details by clicking on the dots.

Explore More

Hotspot

Dive into the research topics where Anthony Nigro is active.

Explore More

Publication

Featured researches published by Anthony Nigro.

Archive | 2005

6,6-Bicyclic ring substituted heterobicyclic protein kinase inhibitors

Lee D. Arnold; Cara Cesario; Heather Coate; Andrew Philip Crew; Hanqing Dong; Kenneth Foreman; Ayako Honda; Radoslaw Laufer; An-Hu Li; Kristen Michelle Mulvihill; Mark J. Mulvihill; Anthony Nigro; Bijoy Panicker; Arno G. Steinig; Yingchuan Sun; Qinghua Weng; Douglas S. Werner; Michael J. Wyle; Tao Zhang

Bioorganic & Medicinal Chemistry | 2008

Novel 2-phenylquinolin-7-yl-derived imidazo[1,5-a]pyrazines as potent insulin-like growth factor-I receptor (IGF-IR) inhibitors

Mark J. Mulvihill; Qun-Sheng Ji; Heather Coate; Andrew Cooke; Hanqing Dong; Lixin Feng; Kenneth Foreman; Maryland Rosenfeld-Franklin; Ayako Honda; Gilda Mak; Kristen Michelle Mulvihill; Anthony Nigro; Matthew O’Connor; Caroline Pirrit; Arno G. Steinig; Kam W. Siu; Kathryn M. Stolz; Yingchuan Sun; Paula A. R. Tavares; Yan Yao; Neil W. Gibson

Archive | 2004

Imidazo[1,5-a]pyrazine tyrosine kinase inhibitors

Patricia Anne Beck; Cara Cesario; Matthew Cox; Hanqing Dong; Kenneth Foreman; Mark J. Mulvihill; Anthony Nigro; Lydia Saroglou; Arno G. Steinig; Yingchuan Sun; Qinghua Weng; Douglas S. Werner; Robin D. Wilkes; Jonathan Williams

Bioorganic & Medicinal Chemistry Letters | 2007

1,3-Disubstituted-imidazo[1,5-a]pyrazines as insulin-like growth-factor-I receptor (IGF-IR) inhibitors

Mark J. Mulvihill; Qun-Sheng Ji; Doug Werner; Patricia Anne Beck; Cara Cesario; Andrew Cooke; Matthew Cox; Andrew P. Crew; Hanqing Dong; Lixin Feng; Kenneth Foreman; Gilda Mak; Anthony Nigro; Matthew O’Connor; Lydia Saroglou; Kathryn M. Stolz; Izabela Sujka; Brian Volk; Qinghua Weng; Robin Wilkes

Archive | 2004

Imidazopyrazine tyrosine kinase inhibitors

Synthesis | 2010

One-Pot FriedländerQuinoline Synthesis: Scope and Limitations

An-Hu Li; David J. Beard; Heather Coate; Ayako Honda; Mridula Kadalbajoo; Andrew Kleinberg; Radoslaw Laufer; Kristen Michelle Mulvihill; Anthony Nigro; Pawan Rastogi; Dan Sherman; Kam W. Siu; Arno G. Steinig; Ti Wang; Doug Werner; Andrew P. Crew; Mark J. Mulvihill

Journal of Organic Chemistry | 2004

Regio- and Stereospecific Syntheses of syn- and anti-1,2-Imidazolylpropylamines from the Reaction of 1,1‘-Carbonyldiimidazole with syn- and anti-1,2-Amino Alcohols

Mark J. Mulvihill; Cara Cesario; Vanessa Smith; Patricia Anne Beck; Anthony Nigro

Bioorganic & Medicinal Chemistry Letters | 2005

Potent and selective [2-imidazol-1-yl-2-(6-alkoxy-naphthalen-2-yl)-1-methyl-ethyl]-dimethyl-amines as retinoic acid metabolic blocking agents (RAMBAs)

Mark J. Mulvihill; Julie L.C. Kan; Patricia Anne Beck; Mark Bittner; Cara Cesario; Andrew Cooke; David M. Keane; Anthony Nigro; Christy Nillson; Vanessa Smith; Mary Srebernak; Feng-Lei Sun; Michael Vrkljan; Shannon L. Winski; Arlindo L. Castelhano; David L. Emerson; Neil W. Gibson

Archive | 2004

Naphthylene derivatives as cytochrome P450 inhibitors

Vanessa Smith; Anthony Nigro; Mark J. Mulvihill; Cara Cesario; Patricia Anne Beck; Arlindo L. Castelhano

Bioorganic & Medicinal Chemistry Letters | 2006

3-[6-(2-Dimethylamino-1-imidazol-1-yl-butyl)-naphthalen-2-yloxy]-2,2-dimethyl-propionic acid as a highly potent and selective retinoic acid metabolic blocking agent

Mark J. Mulvihill; Julie L.C. Kan; Andrew Cooke; Shripad V. Bhagwat; Patricia Anne Beck; Mark Bittner; Cara Cesario; David M. Keane; Viorica Lazarescu; Anthony Nigro; Christy Nillson; Bijoy Panicker; Vanessa Smith; Mary Srebernak; Feng-Lei Sun; Matthew O’Connor; Suzanne Russo; Gia Fischetti; Michael Vrkljan; Shannon L. Winski; Arlindo L. Castelhano; David L. Emerson; Neil W. Gibson

Explore More